BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8179594)

  • 1. Effects of alpha-lipoic acid and dihydrolipoic acid on expression of proto-oncogene c-fos.
    Mizuno M; Packer L
    Biochem Biophys Res Commun; 1994 Apr; 200(2):1136-42. PubMed ID: 8179594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential induction of c-fos and c-jun proto-oncogenes and AP-1 activity by tumor promoter 12-O-tetradecanoyl phorbol 13-acetate in cells at different stages of tumor promotion in vitro.
    Wu WS; Lin JK; Wu FY
    Oncogene; 1992 Nov; 7(11):2287-94. PubMed ID: 1437150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulation of intercellular adhesion molecule 1 by phorbol ester in human neuroblastoma cell line SK-N-SH involves jun- and fos-containing activator protein 1 site binding complex(es).
    Farina AR; Cappabianca L; Mackay AR; Tiberio A; Tacconelli A; Tessitore A; Frati L; Martinotti S; Gulino A
    Cell Growth Differ; 1997 Jul; 8(7):789-800. PubMed ID: 9218873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired induction of c-fos/c-jun genes and of transcriptional regulatory proteins binding distinct c-fos/c-jun promoter elements in activated human T cells during aging.
    Whisler RL; Chen M; Beiqing L; Carle KW
    Cell Immunol; 1997 Jan; 175(1):41-50. PubMed ID: 9015187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immediate early gene expression in dog thyrocytes in response to growth, proliferation, and differentiation stimuli.
    Deleu S; Pirson I; Clermont F; Nakamura T; Dumont JE; Maenhaut C
    J Cell Physiol; 1999 Nov; 181(2):342-54. PubMed ID: 10497313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of c-fos and c-jun mRNA expression by basic fibroblast growth factor in cultured rat Müller cells.
    Cao W; Li F; Steinberg RH; LaVail MM
    Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):565-73. PubMed ID: 9501868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chronic phorbol ester treatment on protein kinase C activity, content, and gene expression in the human monoblastoid U937 cell.
    Ways DK; Qin W; Garris TO; Chen J; Hao E; Cooper DR; Usala SJ; Parker PJ; Cook PP
    Cell Growth Differ; 1994 Feb; 5(2):161-9. PubMed ID: 8180129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successive occupancy by immediate early transcriptional factors of the tyrosine hydroxylase gene TRE and CRE sites in PACAP-stimulated PC12 pheochromocytoma cells.
    Yukimasa N; Isobe K; Nagai H; Takuwa Y; Nakai T
    Neuropeptides; 1999 Dec; 33(6):475-82. PubMed ID: 10657527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phorbol ester-mediated inhibition of growth and regulation of proto-oncogene expression in the human T cell leukemia line JURKAT.
    Makover D; Cuddy M; Yum S; Bradley K; Alpers J; Sukhatme V; Reed JC
    Oncogene; 1991 Mar; 6(3):455-60. PubMed ID: 2011401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phorbol ester treatment of human myometrial cells suppresses expression of oxytocin receptor through a mechanism that does not involve activator protein-1.
    Ball A; Wang JW; Wong S; Zielnik B; Mitchell J; Wang N; Stemerman MB; Mitchell BF
    Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E922-8. PubMed ID: 16757545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of the growth factor-mediated induction of c-fos and down-modulation of AP-1-binding activity are not required for cellular senescence.
    Lucibello FC; Brüsselbach S; Sewing A; Müller R
    Oncogene; 1993 Jun; 8(6):1667-72. PubMed ID: 7684831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling pathways in the induction of c-fos and c-jun proto-oncogenes by 3-methylcholanthrene.
    Ainbinder E; Bergelson S; Daniel V
    Recept Signal Transduct; 1997; 7(4):279-89. PubMed ID: 9633828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phorbol esters support the proliferation of a hematopoietic cell line by upregulating c-jun expression.
    Mayo MW; Steelman LS; McCubrey JA
    Oncogene; 1994 Jul; 9(7):1999-2008. PubMed ID: 8208545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of histone deacetylase inhibitors on phorbol ester- and TGF-beta1 induced murine tissue inhibitor of metalloproteinases-1 gene expression.
    Young DA; Billingham O; Sampieri CL; Edwards DR; Clark IM
    FEBS J; 2005 Apr; 272(8):1912-26. PubMed ID: 15819885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of c-fos and c-jun proteins and AP-1 binding activity during cell cycle progression of HL60 cells and phytohemagglutinin-stimulated lymphocytes.
    Tay DL; Hoffbrand AV; Wickremasinghe GR
    Exp Hematol; 1996 Feb; 24(2):277-84. PubMed ID: 8641353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation and inhibition of the AP-1 complex in human breast cancer cells.
    Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH
    Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1beta up-regulates the expression of thrombopoietin and transcription factors c-Jun, c-Fos, GATA-1, and NF-E2 in megakaryocytic cells.
    Chuen CK; Li K; Yang M; Fok TF; Li CK; Chui CM; Yuen PM
    J Lab Clin Med; 2004 Feb; 143(2):75-88. PubMed ID: 14966463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation-associated genes regulated by TPA-induced c-Jun expression via a PKC/JNK pathway in KYSE450 cells.
    Yu X; Luo A; Zhou C; Ding F; Wu M; Zhan Q; Liu Z
    Biochem Biophys Res Commun; 2006 Mar; 342(1):286-92. PubMed ID: 16480952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the c-fos enhancer by the erk MAP kinase pathway through two sequence elements: the c-fos AP-1 and p62TCF sites.
    Wang Y; Prywes R
    Oncogene; 2000 Mar; 19(11):1379-85. PubMed ID: 10723128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P4502E1- and cytochrome P4502B1/2B2-catalyzed carbon tetrachloride metabolism: effects on signal transduction as demonstrated by altered immediate-early (c-Fos and c-Jun) gene expression and nuclear AP-1 and NF-kappa B transcription factor levels.
    Gruebele A; Zawaski K; Kaplan D; Novak RF
    Drug Metab Dispos; 1996 Jan; 24(1):15-22. PubMed ID: 8825185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.